425: Veeco Supplements Merger Proxy Amid Shareholder Lawsuits
Merger Update
Veeco Instruments Inc. has filed supplemental disclosures to its merger proxy statement with Axcelis Technologies, Inc. in response to multiple stockholder lawsuits challenging the adequacy of prior disclosures.
Summary
- Veeco Instruments Inc. and Axcelis Technologies, Inc. entered into an Agreement and Plan of Merger on September 30, 2025, where Veeco will become a wholly-owned subsidiary of Axcelis.
- Veeco will hold a special meeting of its stockholders on February 6, 2026, at 10:00 a.m. Eastern Time, to vote on the Merger.
- Fifteen demand letters and three complaints (Turner, Clark, and Garfield Actions) have been filed by purported stockholders of Veeco and Axcelis, challenging the adequacy of disclosures in the Preliminary Joint Proxy Statement, Form S-4 Registration Statement, and Definitive Proxy Statement.
- The lawsuits allege negligence, negligent misrepresentation, failure to disclose, and breach of fiduciary duties, seeking to enjoin the Merger or rescission if consummated.
- On January 25, 2026, a motion for a preliminary injunction was filed in the Garfield Action, seeking to enjoin the stockholder vote until the Definitive Proxy is supplemented.
- Veeco and Axcelis deny the allegations and believe the disclosures comply with applicable law, but voluntarily supplemented the Definitive Proxy Statement to avoid the burden and expense of potential litigation and to prevent delay or disruption to the Merger.
- The supplemental disclosures include additional details on the background of the merger, financial analyses from J.P. Morgan (for Axcelis) and UBS (for Veeco), Veeco's financial forecasts, and the interests of Veeco's directors and executive officers in the Merger.
Sentiment
Score: 6
Explanation: The filing confirms a strategic merger with a premium and potential value creation for Veeco stockholders. However, the presence of multiple stockholder lawsuits challenging disclosures and a motion for preliminary injunction introduces significant legal and operational risks, potentially delaying or disrupting the transaction. The voluntary supplemental disclosures aim to mitigate these risks.
Positives
- The August 12, 2025, Axcelis proposal offered a fixed exchange ratio of 0.340x of an Axcelis share for each Veeco share, representing an 18% premium to the average exchange ratio over the one-month period prior to the proposal.
- Veeco stockholders are expected to receive 40% of the ownership of the combined company.
- UBS's combined company discounted cash flow analysis, including cost synergies, indicated a range of implied equity values per share of Veeco common stock of $32.91 to $40.07, which is higher than the standalone implied equity value range of $30.14 to $36.54.
Negatives
- Fifteen demand letters and three stockholder lawsuits have been filed against Veeco and Axcelis, challenging the adequacy of merger disclosures.
- The lawsuits allege serious claims including negligence, negligent misrepresentation, failure to disclose, and breach of fiduciary duties.
- Plaintiffs in the lawsuits are seeking relief that includes enjoining the Merger or rescission if it is consummated.
- A motion for a preliminary injunction was filed to potentially delay the stockholder vote on the Merger.
- Veeco is incurring burden and expense due to potential litigation, despite believing the allegations are without merit.
Risks
- Failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise.
- Failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing.
- Negative effects of the announcement of the proposed transaction.
- Risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies, and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected.
- Disruptions from the proposed transaction harming business plans and operations.
- Risks relating to unanticipated costs of integration.
- Significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities.
- Restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions.
- Potential litigation associated with the proposed transaction.
- The potential impact of the announcement or consummation of the proposed transaction on Axcelis, Veeco's or the combined company's relationships with suppliers, customers, employees and regulators.
- Demand for the combined company's products.
- Economic, political and social conditions in the countries in which Axcelis and Veeco, their respective customers and suppliers operate.
- Disruption to Axcelis and Veeco's respective manufacturing facilities or other operations, or the operations of Axcelis and Veeco's respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism.
- Ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns.
- Axcelis, Veeco's and the combined company's ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry.
- Axcelis, Veeco's and the combined company's ability to maintain their respective technology advantage and protect their respective proprietary rights.
- Axcelis, Veeco's and the combined company's ability to compete with new products introduced by their respective competitors.
- Axcelis, Veeco's and the combined company's ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China.
Future Outlook
The merger is expected to create a combined company with potential benefits, cost savings, accretion, synergies, and growth. The combined company analysis by UBS suggests an increase in implied equity value per share for Veeco stockholders compared to a standalone basis. Axcelis expects to enter into employment arrangements with key employees across the organization post-closing. Veeco's compensation committee may take actions to mitigate potential excise tax impacts on executive officers in the future.
Management Comments
- Veeco and Axcelis believe that the allegations in the Stockholder Actions are without merit.
- The Company denies that the Definitive Proxy Statement is deficient in any respect.
- The Company denies that it has violated any laws or breached any duties to the Company's stockholders, denies all allegations in the Stockholder Actions, and believes no supplemental disclosure to the Definitive Proxy Statement was or is required under any applicable law, rule, or regulation.
- However, solely to eliminate the burden and expense of potential litigation, and to avoid potential delay or disruption to the Merger, the Company has determined to voluntarily supplement the Definitive Proxy Statement with the below disclosures.
Industry Context
The filing details a merger within the semiconductor capital equipment (SemiCap) industry, a sector characterized by continuous technological advancements and strategic consolidation. The financial analyses by UBS and J.P. Morgan utilize comparable companies in both Mid-Cap and Large-Cap SemiCap sectors, underscoring the strategic importance of market positioning and scale. Ongoing discussions between Axcelis and Veeco executives at industry conferences highlight the dynamic nature of the sector and the continuous evaluation of strategic opportunities.
Comparison to Industry Standards
- UBS reviewed publicly available financial and stock market information of Mid-Cap SemiCap companies including ASM International NV, Nova Ltd., Onto Innovation Inc., Camtek Ltd., FormFactor, Inc., and AIXTRON SE.
- UBS also reviewed Large-Cap SemiCap companies such as ASML Holding N.V., Lam Research Corporation, Applied Materials, Inc., KLA Corporation, and Tokyo Electron Limited.
- The analysis included various valuation multiples for these comparable companies, such as EV / 2025E Adjusted EBITDA (ranging from 13.0x to 30.5x for Mid-Cap and 16.6x to 26.7x for Large-Cap), EV / 2026E Adjusted EBITDA, P / 2025E Earnings, and P / 2026E Earnings.
- J.P. Morgan's discounted cash flow analysis for Axcelis and Veeco used perpetuity growth rates ranging from 2.5% to 3.5% and discount rates (WACC) from 10.0% to 11.0% for Veeco and 11.0% to 12.0% for Axcelis.
- UBS's discounted cash flow analysis for Veeco and Axcelis used discount rates (WACC) ranging between 14.0% and 17.0%.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Committee Formation | Formation of the Veeco Strategic Planning Committee (as a committee of convenience) to explore and evaluate strategic alternatives. Members appointed: Mr. DAmore, Dr. Miller, Keith D. Jackson, and Gordon Hunter. The committee was not empowered to make final decisions on transactions. | May 17, 2024 | Aimed at enabling expeditious responses to day-to-day aspects of strategic exploration, without decision-making power, and not due to actual or potential conflict of interest. |
| Director Recusal Policy | Thomas St. Dennis, an independent director on both Axcelis and Veeco boards, recused himself from all meetings where the proposed transaction was discussed and did not receive confidential information related to the transaction. | Ongoing during merger discussions | Mitigates potential conflicts of interest due to dual directorship and enhances governance integrity during merger negotiations. |
Legal Proceedings
- Fifteen demand letters have been received by Veeco and Axcelis from purported stockholders challenging the adequacy of certain disclosures made in the Preliminary Joint Proxy Statement, Form S-4 Registration Statement, and Definitive Proxy Statement.
- Turner v. Veeco Instruments Inc. et al., Index No. 650266/2026 (N.Y. Sup. Ct. Jan. 14, 2026), filed in the Supreme Court of the State of New York, County of New York, names Veeco and its board of directors as defendants, alleging negligence and negligent misrepresentation.
- Clark v. Veeco Instruments Inc. et al., Index No. 650284/2026 (N.Y. Sup. Ct. Jan. 15, 2026), filed in the Supreme Court of the State of New York, County of New York, names Veeco, its board of directors, and Axcelis as defendants, alleging negligence and negligent misrepresentation.
- Garfield v. Bayless et al., Index No. 601340/2026 (N.Y. Sup. Ct. Jan. 20, 2026), filed in the Supreme Court of the State of New York, County of Nassau, names Veeco, its board of directors, and Axcelis as defendants, alleging failure to disclose, breach of fiduciary duties, and aiding and abetting breach of fiduciary duties.
- The Turner Action, Clark Action, and Garfield Action seek, among other relief, an order enjoining the Merger or rescission if the Merger is consummated.
- On January 25, 2026, the plaintiff in the Garfield Action filed a motion for a preliminary injunction, seeking to enjoin Veeco and its directors from closing the stockholder vote on the Merger until the Definitive Proxy is supplemented.
Related Party Transactions
- Thomas St. Dennis serves as an independent director on both the Axcelis board of directors and the Veeco board of directors. He recused himself from relevant discussions and did not receive confidential information concerning the proposed transaction.
- Dr. Russell Low, the Chief Executive Officer of Axcelis, was employed at Veeco as Vice President of Engineering from 2012 to 2016.
- The August 12, 2025, Axcelis Proposal provided that three members of the board of directors of the combined company would be current Veeco directors, one of whom would be Thomas St. Dennis.
- The Veeco Strategic Planning Committee discussed Mr. St. Dennis as a potential Chairperson for the combined company board given his familiarity with both companies and the semiconductor industry.
Stakeholder Impact
- Shareholders: Veeco stockholders are offered a premium and 40% ownership in the combined entity, with an implied equity value increase. However, ongoing lawsuits create uncertainty and potential delays for the merger.
- Employees: Axcelis expects to enter into employment arrangements with key employees across the organization. Executive officers may be subject to 280G excise tax provisions, with potential mitigation actions by Veeco's compensation committee.
- Directors: Veeco non-employee directors' unvested restricted stock awards will fully vest upon merger, entitling them to merger consideration.
- Customers/Suppliers: The merger could impact relationships, as noted in the forward-looking statements, but also potentially lead to a stronger combined entity with broader offerings.
Next Steps
- Veeco will hold a special meeting of its stockholders on February 6, 2026, to vote on the Merger.
- The combined company expects to enter into employment arrangements with key employees across the organization.
- Veeco's compensation committee may take actions in the future to mitigate the impacts of Sections 280G and 4999 of the Internal Revenue Code on executive officers.
Key Dates
| Date | Description |
|---|---|
| May 13, 2024 | Dr. Miller's meeting with Dr. Low regarding potential strategic discussions. |
| May 14, 2024 | Dr. Miller's meeting with Dr. Low regarding potential strategic discussions. |
| May 17, 2024 | Veeco board of directors meeting where the formation of the Veeco Strategic Planning Committee was discussed and approved. |
| August 12, 2025 | Axcelis submitted a written non-binding indication of interest to combine with Veeco in an all-stock transaction. |
| August 13, 2025 | Veeco Strategic Planning Committee meeting where a draft counterproposal was agreed upon. |
| August 19, 2025 | Veeco Strategic Planning Committee meeting to discuss Axcelis's proposal and Veeco's draft counterproposal. |
| August 25, 2025 | Scheduled meeting between representatives of Veeco and Axcelis to discuss proposals. |
| September 11, 2025 | UBS held less than 1% of the outstanding shares of Veeco and Axcelis common stock. |
| September 12, 2025 | End of the two-year period during which UBS did not receive fees from Veeco or Axcelis for financial advisory or investment banking services. |
| September 29, 2025 | Date for the number of fully diluted shares of Veeco and Axcelis common stock outstanding used in UBS's analysis. |
| September 30, 2025 | Veeco Instruments Inc. and Axcelis Technologies, Inc. entered into the Agreement and Plan of Merger; estimated UBS fee of $28.5 million based on information available. |
| December 26, 2025 | Date for which the number and estimated aggregate value of unvested equity awards held by Veeco executive officers and directors were summarized. |
| December 31, 2024 | Axcelis unfunded pension liabilities of approximately $3 million. |
| January 14, 2026 | Turner v. Veeco Instruments Inc. et al. lawsuit filed in the Supreme Court of the State of New York, County of New York. |
| January 15, 2026 | Clark v. Veeco Instruments Inc. et al. lawsuit filed in the Supreme Court of the State of New York, County of New York. |
| January 20, 2026 | Garfield v. Bayless et al. lawsuit filed in the Supreme Court of the State of New York, County of Nassau. |
| January 25, 2026 | Plaintiff in the Garfield Action filed a motion for a preliminary injunction. |
| January 28, 2026 | Date of Report (earliest event reported) for the Form 425 filing. |
| February 6, 2026 | Veeco special meeting of stockholders scheduled for 10:00 a.m., Eastern Time. |
| June 30, 2025 | Date for present value calculations in discounted cash flow analyses; Veeco cash $355M, debt $230M; Axcelis cash $581M, finance leases $43M; Combined company cash $876M. |
| July 1, 2025 through December 31, 2028 | Period for forecasted unlevered free cash flows in discounted cash flow analysis. |
Recommendation
holdWhile the merger presents a strategic opportunity for Veeco stockholders with an offered premium and an implied increase in equity value for the combined entity, the ongoing stockholder lawsuits and the motion for a preliminary injunction introduce significant uncertainty and potential delays. The voluntary supplemental disclosures aim to address these legal challenges, but the outcome of the litigation remains a key risk factor. Investors should hold their positions pending further clarity on the legal proceedings and the definitive completion of the merger.
Keywords
Veeco Instruments, Axcelis Technologies, Merger Agreement, SEC Filing, Form 425, Stockholder Lawsuits, Proxy Statement, Semiconductor Equipment, Corporate Governance, Financial Analysis, M&A, Litigation Risk, Shareholder Vote, Disclosure Supplement
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.